These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18289851)

  • 1. 3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activity.
    Hoyt SB; London C; Wyvratt MJ; Fisher MH; Cashen DE; Felix JP; Garcia ML; Li X; Lyons KA; Euan MacIntyre D; Martin WJ; Priest BT; Smith MM; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1963-6. PubMed ID: 18289851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzazepinone Nav1.7 blockers: potential treatments for neuropathic pain.
    Hoyt SB; London C; Ok H; Gonzalez E; Duffy JL; Abbadie C; Dean B; Felix JP; Garcia ML; Jochnowitz N; Karanam BV; Li X; Lyons KA; McGowan E; Macintyre DE; Martin WJ; Priest BT; Smith MM; Tschirret-Guth R; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6172-7. PubMed ID: 17889534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers.
    Ok D; Li C; Abbadie C; Felix JP; Fisher MH; Garcia ML; Kaczorowski GJ; Lyons KA; Martin WJ; Priest BT; Smith MM; Williams BS; Wyvratt MJ; Parsons WH
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1358-61. PubMed ID: 16337121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.
    Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME
    Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.
    Hoyt SB; London C; Gorin D; Wyvratt MJ; Fisher MH; Abbadie C; Felix JP; Garcia ML; Li X; Lyons KA; McGowan E; MacIntyre DE; Martin WJ; Priest BT; Ritter A; Smith MM; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4630-4. PubMed ID: 17588748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of pyrrolidine derivatives as novel and potent sodium channel blockers for the treatment of ischemic stroke.
    Seki M; Tsuruta O; Tatsumi R; Soejima A
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4230-4. PubMed ID: 23743284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers.
    Ma X; Poon TY; Wong PT; Chui WK
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5644-7. PubMed ID: 19716698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GBR12909 possesses anticonvulsant activity in zebrafish and rodent models of generalized epilepsy but cardiac ion channel effects limit its clinical utility.
    Goldsmith P; Golder Z; Hunt J; Berghmans S; Jones D; Stables JP; Murphree L; Howden D; Newton PE; Richards FM
    Pharmacology; 2007; 79(4):250-8. PubMed ID: 17476122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyamide analogs of propofol exhibit state-dependent block of sodium channels in hippocampal neurons: implications for anticonvulsant activity.
    Jones PJ; Wang Y; Smith MD; Hargus NJ; Eidam HS; White HS; Kapur J; Brown ML; Patel MK
    J Pharmacol Exp Ther; 2007 Feb; 320(2):828-36. PubMed ID: 17090703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazopyridines: a novel class of hNav1.7 channel blockers.
    London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons.
    Liu Y; Yohrling GJ; Wang Y; Hutchinson TL; Brenneman DE; Flores CM; Zhao B
    Epilepsy Res; 2009 Jan; 83(1):66-72. PubMed ID: 19013768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
    Liberatore AM; Schulz J; Pommier J; Barthelemy MA; Huchet M; Chabrier PE; Bigg D
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3521-3. PubMed ID: 15177465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of potent and use-dependent sodium channel blockers for treatment of chronic pain.
    Liang J; Brochu RM; Cohen CJ; Dick IE; Felix JP; Fisher MH; Garcia ML; Kaczorowski GJ; Lyons KA; Meinke PT; Priest BT; Schmalhofer WA; Smith MM; Tarpley JW; Williams BS; Martin WJ; Parsons WH
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2943-7. PubMed ID: 15878274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constrained analogues of tocainide as potent skeletal muscle sodium channel blockers towards the development of antimyotonic agents.
    Catalano A; Carocci A; Corbo F; Franchini C; Muraglia M; Scilimati A; De Bellis M; De Luca A; Camerino DC; Sinicropi MS; Tortorella V
    Eur J Med Chem; 2008 Nov; 43(11):2535-40. PubMed ID: 18342401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity.
    Gómez-Varela D; Zwick-Wallasch E; Knötgen H; Sánchez A; Hettmann T; Ossipov D; Weseloh R; Contreras-Jurado C; Rothe M; Stühmer W; Pardo LA
    Cancer Res; 2007 Aug; 67(15):7343-9. PubMed ID: 17671204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(4-phenoxyphenyl)pyrazoles: a novel class of sodium channel blockers.
    Yang J; Gharagozloo P; Yao J; Ilyin VI; Carter RB; Nguyen P; Robledo S; Woodward RM; Hogenkamp DJ
    J Med Chem; 2004 Mar; 47(6):1547-52. PubMed ID: 14998340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereospecific synthesis of "para-hydroxymexiletine" and sodium channel blocking activity evaluation.
    Catalano A; Carocci A; Fracchiolla G; Franchini C; Lentini G; Tortorella V; De Luca A; De Bellis M; Desaphy JF; Conte Camerino D
    Chirality; 2004 Feb; 16(2):72-8. PubMed ID: 14712469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives.
    Kort ME; Atkinson RN; Thomas JB; Drizin I; Johnson MS; Secrest MA; Gregg RJ; Scanio MJ; Shi L; Hakeem AH; Matulenko MA; Chapman ML; Krambis MJ; Liu D; Shieh CC; Zhang X; Simler G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Werness S; Antonio B; Marsh KC; Faltynek CR; Krafte DS; Jarvis MF; Marron BE
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6812-5. PubMed ID: 20855211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of voltage-gated sodium channels in sensory neurones.
    Docherty RJ; Farmer CE
    Handb Exp Pharmacol; 2009; (194):519-61. PubMed ID: 19655117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyl 2-(4-[1.1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain.
    Liberatore AM; Schulz J; Favre-Guilmard C; Pommier J; Lannoy J; Pawlowski E; Barthelemy MA; Huchet M; Auguet M; Chabrier PE; Bigg D
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1746-9. PubMed ID: 17234409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.